BC25286100 | 藥品資訊 | 疾病管制署傳染病

PREZISTA (darunavir)是一種人類免疫不全病毒(HIV)蛋白酶抑制劑。 Binds to the site of HIV-1 protease activity and inhibits cleavage of viral Gag-Pol polyprotein ... Read More

成份及含量, Darunavir 400mg/tab, 藥理分類三, 08180808 Anti－infective agents/​Antivirals/Antiretrovirals/HIV protease inhibitors. 劑型, 116膜衣錠, 檔案下載 ... Read More

Darunavir is a nonpeptidic inhibitor of protease (PR) that lodges itself in the active site of PR through a number of hydrogen bonds. ... It was developed to increase ... Read More

Darunavir is a human immunodeficiency virus type 1 (HIV-1) protease nonpeptidic inhibitor, with activity against HIV. Upon oral administration, darunavir ... Read More

Introduction. Darunavir is an HIV protease inhibitor for use in combination therapy of HIV infection in previously treated adults. Darunavir ... Read More

由 KC Brown 著作 — MECHANISMS OF ACTION. Darunavir selectively blocks the cleavage of the HIV Gag-Pol polyprotein by inhibiting the HIV-1 protease enzyme. This mechanism ... Read More

由 K McKeage 著作 · 2009 · 被引用 123 次 — Boosted darunavir was generally well tolerated in patients with HIV-1 infection in clinical trials, with most events being mild to moderate in severity. At 48-week ... Read More

Darunavir is a HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection in patients with history of prior antiretroviral ... Read More

2017年9月20日 — Treatment-experienced without darunavir resistance-associated substitutions, 800mg PO qd concomitantly with ritonavir 100 mg PO qd, with ... Read More